

46. Gastroenterology. 2015 Jan;148(1):221-244.e3. doi: 10.1053/j.gastro.2014.10.038. 
Epub 2014 Oct 31.

American Gastroenterological Association Institute technical review on prevention
and treatment of hepatitis B virus reactivation during immunosuppressive drug
therapy.

Perrillo RP(1), Gish R(2), Falck-Ytter YT(3).

Author information: 
(1)Hepatology Division, Baylor University Medical Center, Department of Medicine,
University of Texas Southwestern, Dallas, Texas.
(2)Division of Gastroenterology and Hepatology, Department of Medicine,Stanford
University, Palo Alto, California; Hepatitis B Foundation, Doylestown,
Pennsylvania.
(3)Division of Gastroenterology and Hepatology, Department of Medicine, Case and 
VA Medical Center, Case Western Reserve University, Cleveland, Ohio.

DOI: 10.1053/j.gastro.2014.10.038 
PMID: 25447852  [Indexed for MEDLINE]
